UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells

Annals of oncology, 1998, Vol.9 (suppl-5), p.S129-S132

1998

Volltextzugriff (PDF)

Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Treatment of Patients With EBV-Positive Relapsed Hodgkin’s Disease

Blood, 1998-04, Vol.91 (8), p.2925-2934

1998

Volltextzugriff (PDF)

Autoimmune disease induced by dendritic cell immunization against leukemia

Leukemia research, 1999-06, Vol.23 (6), p.549-557

1999

Volltextzugriff (PDF)

Recent developments in gene therapy for oncology and hematology

Critical reviews in oncology/hematology, 1998-09, Vol.28 (3), p.139-151

1998

Volltextzugriff (PDF)

The generation of LMP2a‐specific cytotoxic T lymphocytes for the treatment of patients with Epstein‐Barr virus‐positive Hodgkin disease

European journal of immunology, 2001-03, Vol.31 (3), p.947-958

2001

Volltextzugriff (PDF)

Tumor vaccines - application to childhood cancer

Klinische Pädiatrie, 1999-07, Vol.211 (4), p.336-346

1999

Volltextzugriff (PDF)

Immunotherapy for Epstein-Barr Virus-Associated Cancers

Journal of the National Cancer Institute. Monographs, 1998, Vol.1998 (23), p.89-93

1998

Volltextzugriff (PDF)

Selective automatic neuropathy as a novel complication of BMT

Bone marrow transplantation (Basingstoke), 1992-11, Vol.10 (5), p.469-470

1992

Volltextzugriff (PDF)

Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism

Leukemia & lymphoma, 2002, Vol.43 (8), p.1651-1662

2002

Volltextzugriff (PDF)

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

Human gene therapy, 1998-05, Vol.9 (8), p.1237-1250

1998

Volltextzugriff (PDF)

The Human Erythroid-Specific Transcription Factor EKLF Localizes to Chromosome 19p13.12–p13.13

Genomics (San Diego, Calif.), 1997-02, Vol.39 (3), p.393-395

1997

Volltextzugriff (PDF)

Cellular immunotherapy of EBV-associated lymphomas

Hematology and cell therapy (Print), 1998, Vol.40 (2), p.79-82

1998

Volltextzugriff (PDF)

The human erythroid-specific transcription factor EKF localizes to chromosome 19p13.12-p13.13

Genomics (San Diego, Calif.), 1997, Vol.39 (3), p.393-395

1997

Volltextzugriff (PDF)

Immunotherapy for Epstein-Barr Virus-Associated Cancers

Journal of the National Cancer Institute. Monographs, 1998-04, Vol.23, p.89-93

1998

Volltextzugriff (PDF)

Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia

British journal of haematology, 2000-11, Vol.111 (2), p.596-607

2000

Volltextzugriff (PDF)

A feasibility study to establish recruitment and immunmonitoring for a first in man study of a therapeutic H. pylori vaccine in healthy infected volunteers

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

CD40 ligand induces an antileukemia immune response in vivo

Blood, 1997-09, Vol.90 (5), p.1927-1933

1997

Volltextzugriff (PDF)

Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

Leukemia, 2001-02, Vol.15 (2), p.246-255

2001

Volltextzugriff (PDF)

CCL3/MIP-1α is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine

Human gene therapy, 2004, Vol.15 (1), p.21-34

2004

Volltextzugriff (PDF)

Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis

British journal of haematology, 2000-12, Vol.111 (3), p.817-825

2000

Volltextzugriff (PDF)

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia

Gene therapy, 2005-12, Vol.12 (23), p.1707-1717

2005

Volltextzugriff (PDF)

Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant

Bone marrow transplantation (Basingstoke), 2001, Vol.27 (1), p.53-64

2001

Volltextzugriff (PDF)

In-vivo generation of leukaemia-derived dendritic cells

Best practice & research. Clinical haematology, 2004, Vol.17 (3), p.439-451

2004

Volltextzugriff (PDF)

Tumor vaccines - application to childhood cancer

Klinische Pädiatrie, 1999-07, Vol.211 (4), p.336-346

1999

Volltextzugriff (PDF)

Adoptive Immunotherapy in Chimeras with Donor Lymphocytes

Acta Haematologica, 2003, Vol.110 (2-3), p.110-120

2003

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)
Tagungsberichte
(2)

Sprache

Englisch
(32)
Deutsch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells

Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Treatment of Patients With EBV-Positive Relapsed Hodgkin’s Disease

Autoimmune disease induced by dendritic cell immunization against leukemia

Recent developments in gene therapy for oncology and hematology

The generation of LMP2a‐specific cytotoxic T lymphocytes for the treatment of patients with Epstein‐Barr virus‐positive Hodgkin disease

Tumor vaccines - application to childhood cancer

Immunotherapy for Epstein-Barr Virus-Associated Cancers

Selective automatic neuropathy as a novel complication of BMT

Antigen Presenting Cells Transfected with LMP2a RNA Induce CD4 + LMP2a-specific Cytotoxic T Lymphocytes which Kill via a Fas-independent Mechanism

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease

The Human Erythroid-Specific Transcription Factor EKLF Localizes to Chromosome 19p13.12–p13.13

Cellular immunotherapy of EBV-associated lymphomas

The human erythroid-specific transcription factor EKF localizes to chromosome 19p13.12-p13.13

Immunotherapy for Epstein-Barr Virus-Associated Cancers

Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia

A feasibility study to establish recruitment and immunmonitoring for a first in man study of a therapeutic H. pylori vaccine in healthy infected volunteers

CD40 ligand induces an antileukemia immune response in vivo

Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

CCL3/MIP-1α is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine

Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia

Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant

In-vivo generation of leukaemia-derived dendritic cells

Tumor vaccines - application to childhood cancer

Adoptive Immunotherapy in Chimeras with Donor Lymphocytes

Suchergebnisse filtern